Trading on the OTCQB Venture Market in the US

Summary by AI BETAClose X

Abingdon Health plc announced that its ordinary shares will commence trading on the OTCQB Venture Market in the United States under the ticker symbol "ABDXF" starting next month, aiming to increase liquidity and attract a broader investor base. This move coincides with the ongoing second phase of a facility expansion at its Madison, Wisconsin site, which began in September 2025 and was funded in October 2025, allowing for manufacturing in both the US and UK under consistent quality standards. The company will continue to trade on AIM under "ABDX" and will not face additional SEC reporting obligations due to its Foreign Private Issuer status.

Disclaimer*

UK 100

Latest directors dealings